MAPT and nasopharyngeal carcinoma: Unexpectedly, we found that loss of APP in the NPC brain leads to a dramatic deterioration of the disease phenotype, including earlier disease onset and a shorter life-span, as well as exacerbation of cholesterol dysregulation, tau hyperphosphorylation, and inflammation [9].